XTANT MEDICAL HOLDINGS, INC. Provision for Other Credit Losses
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Provision for Other Credit Losses of $330.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForOtherCreditLosses · last filed 2024-11-12
- XTANT MEDICAL HOLDINGS, INC. provision for other credit losses for the quarter ending 2023-12-31 was $181.00K.
- XTANT MEDICAL HOLDINGS, INC. provision for other credit losses for the quarter ending 2023-09-30 was $91.00K, a 68.52% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. provision for other credit losses for the quarter ending 2023-06-30 was $119.00K.
- XTANT MEDICAL HOLDINGS, INC. provision for other credit losses for the quarter ending 2023-03-31 was $106.00K, a 44.50% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. provision for other credit losses for fiscal 2023 was $497.00K, a 104.53% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. provision for other credit losses for fiscal 2022 was $243.00K, a 440.00% increase from fiscal 2021.
- XTANT MEDICAL HOLDINGS, INC. provision for other credit losses for fiscal 2021 was $45.00K.
| Period end | Provision for Other Credit Losses 3 month | Provision for Other Credit Losses 3 month as first filed | Provision for Other Credit Losses 6 month | Provision for Other Credit Losses 9 month | Provision for Other Credit Losses 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $330.00K 10-Q · filed 2024-11-12 | ||||
| 2023-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $272.00K derived: sum of 2 quarters · filed 2024-04-01 | $391.00K derived: sum of 3 quarters · filed 2024-04-01 | $497.00K 10-K · filed 2024-04-01 | |
| 2023-09-30 | $91.00K derived: 10-K 12 month − 3 quarters · filed 2024-04-01 | $210.00K derived: sum of 2 quarters · filed 2024-04-01 | $316.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $119.00K 10-Q · filed 2023-08-01 | $225.00K derived: sum of 2 quarters · filed 2023-08-01 | |||
| 2023-03-31 | $106.00K 10-Q · filed 2023-08-01 | ||||
| 2022-12-31 | $243.00K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $54.00K 10-Q · filed 2022-11-03 | $5.00K derived: sum of 2 quarters · filed 2023-08-01 | $196.00K derived: sum of 3 quarters · filed 2023-08-01 | ||
| 2022-06-30 | -$49.00K 10-Q · filed 2023-08-01 | $49.00K 10-Q · filed 2022-11-03 | $142.00K derived: sum of 2 quarters · filed 2023-08-01 | ||
| 2022-03-31 | $191.00K 10-Q · filed 2023-08-01 | ||||
| 2021-12-31 | $45.00K 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $118.00K 10-Q · filed 2022-11-03 | $199.00K derived: sum of 2 quarters · filed 2022-11-03 | $262.00K derived: sum of 3 quarters · filed 2022-11-03 | ||
| 2021-06-30 | $81.00K 10-Q · filed 2022-11-03 | $144.00K derived: sum of 2 quarters · filed 2022-11-03 | |||
| 2021-03-31 | $63.00K 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |